Morgan Stanley’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.07M Buy
550,607
+165,620
+43% +$1.83M ﹤0.01% 3894
2025
Q1
$3.44M Sell
384,987
-7,346
-2% -$65.6K ﹤0.01% 4226
2024
Q4
$3.69M Sell
392,333
-103,480
-21% -$974K ﹤0.01% 4250
2024
Q3
$4M Buy
495,813
+36,890
+8% +$297K ﹤0.01% 4129
2024
Q2
$3.89M Buy
458,923
+39,810
+9% +$338K ﹤0.01% 4091
2024
Q1
$3.76M Sell
419,113
-107,785
-20% -$967K ﹤0.01% 4143
2023
Q4
$5.92M Buy
526,898
+274,277
+109% +$3.08M ﹤0.01% 4278
2023
Q3
$2.18M Buy
252,621
+29,394
+13% +$254K ﹤0.01% 4343
2023
Q2
$2.31M Sell
223,227
-129,676
-37% -$1.34M ﹤0.01% 4330
2023
Q1
$3.83M Sell
352,903
-134,920
-28% -$1.46M ﹤0.01% 3993
2022
Q4
$5.47M Sell
487,823
-110,842
-19% -$1.24M ﹤0.01% 3676
2022
Q3
$6.07M Buy
598,665
+205,080
+52% +$2.08M ﹤0.01% 3508
2022
Q2
$3.57M Sell
393,585
-276,419
-41% -$2.5M ﹤0.01% 4063
2022
Q1
$6.41M Sell
670,004
-809,025
-55% -$7.73M ﹤0.01% 3412
2021
Q4
$16.3M Buy
1,479,029
+950,477
+180% +$10.5M ﹤0.01% 2380
2021
Q3
$3.91M Buy
528,552
+80,582
+18% +$596K ﹤0.01% 3980
2021
Q2
$6.5M Buy
447,970
+289,099
+182% +$4.2M ﹤0.01% 3497
2021
Q1
$3.24M Sell
158,871
-431,110
-73% -$8.8M ﹤0.01% 3852
2020
Q4
$10.5M Buy
589,981
+467,538
+382% +$8.31M ﹤0.01% 2463
2020
Q3
$1.81M Sell
122,443
-280,092
-70% -$4.14M ﹤0.01% 3744
2020
Q2
$8.45M Sell
402,535
-145,135
-27% -$3.05M ﹤0.01% 2121
2020
Q1
$12.7M Sell
547,670
-57,186
-9% -$1.32M ﹤0.01% 1598
2019
Q4
$15.7M Buy
604,856
+100,848
+20% +$2.61M ﹤0.01% 1893
2019
Q3
$9.82M Sell
504,008
-55,082
-10% -$1.07M ﹤0.01% 2151
2019
Q2
$9.13M Sell
559,090
-128,302
-19% -$2.1M ﹤0.01% 2265
2019
Q1
$15.6M Buy
687,392
+61,241
+10% +$1.39M ﹤0.01% 1635
2018
Q4
$16M Buy
626,151
+508,426
+432% +$13M ﹤0.01% 1661
2018
Q3
$3.85M Buy
117,725
+15,919
+16% +$520K ﹤0.01% 3458
2018
Q2
$2.31M Buy
101,806
+154
+0.2% +$3.49K ﹤0.01% 3933
2018
Q1
$2.47M Buy
101,652
+5,415
+6% +$131K ﹤0.01% 3793
2017
Q4
$2.68M Buy
96,237
+33,051
+52% +$922K ﹤0.01% 3758
2017
Q3
$2.16M Sell
63,186
-10,620
-14% -$364K ﹤0.01% 3810
2017
Q2
$2.94M Buy
73,806
+6,688
+10% +$266K ﹤0.01% 3424
2017
Q1
$2.47M Sell
67,118
-55,404
-45% -$2.04M ﹤0.01% 3617
2016
Q4
$3.91M Buy
122,522
+95,272
+350% +$3.04M ﹤0.01% 3257
2016
Q3
$987K Sell
27,250
-5,547
-17% -$201K ﹤0.01% 4052
2016
Q2
$745K Buy
32,797
+24,983
+320% +$568K ﹤0.01% 4189
2016
Q1
$147K Buy
7,814
+1,831
+31% +$34.4K ﹤0.01% 5145
2015
Q4
$98K Buy
5,983
+444
+8% +$7.27K ﹤0.01% 5417
2015
Q3
$61K Sell
5,539
-16,055
-74% -$177K ﹤0.01% 5652
2015
Q2
$281K Buy
21,594
+9,643
+81% +$125K ﹤0.01% 5072
2015
Q1
$207K Sell
11,951
-163,752
-93% -$2.84M ﹤0.01% 5188
2014
Q4
$2.62M Buy
175,703
+80,845
+85% +$1.21M ﹤0.01% 3316
2014
Q3
$2.19M Buy
94,858
+88,134
+1,311% +$2.03M ﹤0.01% 3356
2014
Q2
$214K Buy
+6,724
New +$214K ﹤0.01% 5115